Applications Published 12 September 2002
Published: 17-May-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Utilisation of cation-active mixtures
Cognis Deutschland 1131046*Oil bodies as topical delivery vehicles for active agents
SemBioSys Genetics 1131047* Galenic formulations fast disintegrating in the mouth and method for preparing same
CLL Pharma 1131050*Pressurised metered dose inhalers
Chiesi Farmaceutici 1131051*Vaginally administrable progesterone-containing tablets and method for preparing same
Ferring 1131052*Nanocapsules and method of production thereof
Novosom 1131053*Methods for preparing coated drug particles and pharmaceutical formulations thereof
University of Florida 1131054*Treatment set containing lung surfactant compsns
Byk Gulden Lomberg Chemische Fabrik 1131055*Particles based on polyamino-acid(s) and methods for preparing same
Flamel Technologies 1131056*Local delivery of drugs to the colon for loca ltreatment of colonic diseases
Dexxon 1131058*Dry powder for inhalation
Jago Research 1131059*Methods for treating, preventing and reducing the risk of onset of Alzheimer's disease usinh an HMG CoA reductase inhibitor
Nymox Corp 1131060*Agent for lowering prolactin
Bionorica 1131061*Injectable propofol formulations
Veterinary Research Associates 1131062*Hyperforin as cytostatic agent and hyperforin ointment or cream as application form
Universitatsklinikum Freiburg 1131063*Use of benzoguanidines for the treatment of non-insulin dependent diabetes mellitus
Merck Patent 1131064*Utilisation of dialkylfumarates
Fumapharm 1131065*Oral creatine supplementation for treating or preventing muscle disuse syndrome
KU Leuven R&D 1131066*Compsn and use of RAR antagonists for promoting chrondrogenesis
The University of Western Ontario 1131067*Compsns of and process for producing isotretinoin having low particle size
F Hoffmann-La Roche 1131068*Method fro treating a patient with neoplasia by treatment with a platinum coordination complex
Cell Pathways 1131069*Pharmaceutical compsn for modified release of an insulin sensitiser and another antidiabetic agent
SmithKline Beecham 1131070*Nicotine-containing pharmaceutical compsns giving a rapid transmucosal absorption
Pharmacia Aktienbolag 1131071*Pharmaceutical combination preparations of carvedilol and hydrochlorothiazide
F Hoffmann-La Roche 1131072*Use of staurosporine derivatives for treating occular neovascular diseases
Novartis 1131073*Use of dehydroepiandrosterone for increasing the number of NMDA receptors in a mammal
L'Universite Paris 1131074*Use of phosphonoformic acid derivatives for treating infections
Jomaa, Hassan 1131075*Method for treating a patient with neoplasia by treatment with an anthracycline antibiotic
Cell Pathways 1131076*Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
Baxter International 1131077*Compsns and methods for recombinational cloning of nucleic acid molecules
Invitrogen 1131078*Small functional units of antibody heavy chain variable regions
Peptor 1131079*Selection and use of lactic acid bacteria strains modulating non-specific activity
Comagnie Gervais-Danone 1131080*Stimulation of angiogenesis via syndecan-4 cytoplasmic domain signalling pathway
Beth Israel Deaconess Medical Centre 1131081*A method for treating tissue damaged from ischaemia
Research Corp Technologies 1131082*Treatment of tumours by administration of growth hormone releasing compounds and their antagonists
ASTA Medica 1131083*Inhibition of differentiation of cytotoxic T-cells by P-selectin ligand (PSGL) antagonists
Genetics Institute 1131084*Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
Broliden, Kristina 1131085*NF-AT mediates cardiac hypertrophy, methods and reagents related thereto
The Board of Trustees of the Leland Stanford Junior University 1131086*Methods of allieviating cancer symptoms
Curis 1131087*NF-(k)B activation inhibitors, and their pharmaceutical uses
Centre National de la Recherche Scientifique 1131088*method of using PON-1 to decrease atheroma formation
Bayer 1131089*Method of treating viral haemorrhagic fever
Eli Lilly 1131090*Treatment of haematologic malignancies associated with circulating tunour cells using chimeric anti-CD20 antibody
IDEC Pharmaceuticals 1131091*
